These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 8297601

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S.
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [Abstract] [Full Text] [Related]

  • 26. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
    Osterhaus AD, van Wezel AL, van Steenis B, Drost GA, Hazendonk TG.
    Intervirology; 1981 Nov; 16(4):218-24. PubMed ID: 6177658
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
    Larbaigt G, Moulin J, Souvras M, Gibelin N, Beranger G.
    Dev Biol Stand; 1981 Nov; 47():113-8. PubMed ID: 6262141
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
    Crainic R, Blondel B, Aubert-Combiescu A, Beytout D, Couillin P, Candrea A, Boué A, Horaud F.
    Dev Biol Stand; 1984 Nov; 57():165-70. PubMed ID: 6084607
    [Abstract] [Full Text] [Related]

  • 33. Rapid and accurate identification of poliovirus strains used for vaccine production.
    Nijst OE, Mouthaan JJ, Mekkes DR, Jusic E, van der Avoort HG, Metz B.
    J Virol Methods; 2013 Apr; 189(1):189-95. PubMed ID: 23434540
    [Abstract] [Full Text] [Related]

  • 34. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody.
    Moynihan M, Ladefoged P, Mathiesen L.
    Dev Biol Stand; 1980 Apr; 46():203-6. PubMed ID: 6244998
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.
    Dragunsky EM, Ivanov AP, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM.
    J Infect Dis; 2006 Sep 15; 194(6):804-7. PubMed ID: 16941347
    [Abstract] [Full Text] [Related]

  • 40. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
    Payment P, Trudel M, Thibodeau L, Lecomte J.
    Can J Microbiol; 1989 May 15; 35(5):550-3. PubMed ID: 2545322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.